| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial
|
Eggermont, Alexander M.M.
|
|
|
133 |
C |
p. 94-103
|
article
|
| 2 |
Association of heterogeneous MYCN amplification with clinical features, biological characteristics and outcomes in neuroblastoma: A report from the Children's Oncology Group
|
Campbell, Kevin
|
|
|
133 |
C |
p. 112-119
|
article
|
| 3 |
Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it!
|
Omarini, Claudia
|
|
|
133 |
C |
p. 29-32
|
article
|
| 4 |
Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non–small-cell lung cancer
|
Yim, Jeemin
|
|
|
133 |
C |
p. 74-85
|
article
|
| 5 |
Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R)
|
Choi, Min C.
|
|
|
133 |
C |
p. 56-65
|
article
|
| 6 |
Immunotherapy-related hepatitis and thrombocytopaenia induced by the very low dose of only 90 mg of atezolizumab
|
Tsukita, Yoko
|
|
|
133 |
C |
p. 22-24
|
article
|
| 7 |
Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study
|
van Weelden, Willem Jan
|
|
|
133 |
C |
p. 104-111
|
article
|
| 8 |
Incidence of and risk factors for late cholecystectomy in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study
|
Dieffenbach, Bryan V.
|
|
|
133 |
C |
p. 4-13
|
article
|
| 9 |
Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial
|
Janoray, Guillaume
|
|
|
133 |
C |
p. 86-93
|
article
|
| 10 |
Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer
|
Matsuo, Koji
|
|
|
133 |
C |
p. 33-46
|
article
|
| 11 |
Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study
|
Dummer, Reinhard
|
|
|
133 |
C |
p. 120-130
|
article
|
| 12 |
Precision oncology: the intention-to-treat analysis fallacy
|
Sicklick, Jason K.
|
|
|
133 |
C |
p. 25-28
|
article
|
| 13 |
SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome
|
Di Giacomo, Anna M.
|
|
|
133 |
C |
p. 1-3
|
article
|
| 14 |
Survival of patients with early-stage cervical cancer after abdominal or laparoscopic radical hysterectomy: a nationwide cohort study and literature review
|
Wenzel, Hans H.B.
|
|
|
133 |
C |
p. 14-21
|
article
|
| 15 |
The impact of RB1 genotype on incidence of second tumours in heritable retinoblastoma
|
Ketteler, Petra
|
|
|
133 |
C |
p. 47-55
|
article
|
| 16 |
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial
|
Pasqualetti, Giuseppe
|
|
|
133 |
C |
p. 66-73
|
article
|
Journal description